Author:
Quednow Boris B.,Engeli Etna J. E.,Herdener Marcus
Publisher
Springer International Publishing
Reference96 articles.
1. Abdallah CG, De Feyter HM, Averill LA, Jiang L, Averill CL, Chowdhury GMI, Purohit P, de Graaf RA, Esterlis I, Juchem C, Pittman BP, Krystal JH, Rothman DL, Sanacora G, Mason GF. The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects. Neuropsychopharmacology. 2018;43(10):2154–60.
2. Allain F, Minogianis E-A, Roberts DCS, Samaha A-N. How fast and how often: the pharmacokinetics of drug use are decisive in addiction. Neurosci Biobehav Rev. 2015;56:166–79.
3. American Psychiatric Association. Practice guideline for the treatment of patients with substance use disorders. Arlington: American Psychiatric Association; 2010.
4. Balster RL, Schuster CR. Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion Duration1. J Exp Anal Behav. 1973;20(1):119–29.
5. Berk M, Malhi GS, Gray LJ, Dean OM. The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci. 2013;34(3):167–77.